Home » Topics » Regulatory

Regulatory
RSS

FDA approves Leukine for H-ARS

April 3, 2018

Sujanu combination tablets approved in Japan

March 28, 2018

Velcade approved in Japan for primary macroglobulinemia and lymphoplasmacytic lymphoma

March 27, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

Japanese approval for Orkedia

March 27, 2018

Lenvima approved in Japan for unresectable HCC

March 26, 2018

European Commission approves Alofisel

March 26, 2018

FDA expands Tasigna indications for pediatric patients with CML

March 23, 2018

Lokelma receives E.U. approval for hyperkalemia

March 23, 2018

FDA approves Ilumya for moderate to severe plaque psoriasis

March 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...